Denali Therapeutics Stock Price

-8.55 (-10.49%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Denali Therapeutics Inc DNLI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-8.55 -10.49% 72.98 18:59:12
Open Price Low Price High Price Close Price Prev Close
81.42 72.67 83.9845 72.98 81.53
Bid Price Ask Price Spread News
73.25 74.00 0.75 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
9,332 520,119 $ 78.43 $ 40,792,568 742,543 12.39 - 93.94
Last Trade Time Type Quantity Stock Price Currency
19:58:05 15 $ 73.50 USD

Denali Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 8.75B 119.92M 73.90M $ 26.68M $ - -2.07 -35.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Denali Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical DNLI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week73.5083.984572.6777.84485,881-0.52-0.71%
1 Month86.5187.50564.5775.24626,855-13.53-15.64%
3 Months44.0093.9443.1371.89740,50228.9865.86%
6 Months23.2093.9422.7552.00713,69749.78214.57%
1 Year25.0093.9412.3938.89648,88947.98191.92%
3 Years21.3793.9412.3228.64465,23051.61241.51%
5 Years21.5593.9412.3228.19467,81051.43238.65%

Denali Therapeutics Description

Denali Therapeutics Inc is a biotechnology company which is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include LRRK2 Inhibitor Program which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle) and others.

Your Recent History
Denali The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.